MORANO, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 75
NA - Nord America 75
AS - Asia 38
Totale 188
Nazione #
US - Stati Uniti d'America 72
IT - Italia 41
IE - Irlanda 15
HK - Hong Kong 14
CN - Cina 13
JO - Giordania 8
CH - Svizzera 7
SE - Svezia 7
CA - Canada 3
GB - Regno Unito 2
CZ - Repubblica Ceca 1
FI - Finlandia 1
FR - Francia 1
IN - India 1
SG - Singapore 1
TH - Thailandia 1
Totale 188
Città #
Dublin 15
Chandler 12
Hong Kong 12
Arezzo 8
Ashburn 7
Bern 7
Florence 7
Rome 5
Lawrence 4
Modena 4
New York 4
Shanghai 4
Wilmington 4
Cambridge 3
Fairfield 3
Mississauga 3
Altamura 2
Beijing 2
Boardman 2
Bologna 2
Boston 2
Buffalo 2
Chengdu 2
Houston 2
Lurate Caccivio 2
Prad am Stilfser Joch 2
Princeton 2
Udine 2
Vicopisano 2
Ann Arbor 1
Bagno a Ripoli 1
Bangkok 1
Brno 1
Cardiff 1
Castel San Giovanni 1
Helsinki 1
Hillsboro 1
Milan 1
Norwalk 1
Paris 1
Pune 1
San Diego 1
San Marco dei Cavoti 1
Saronno 1
Seattle 1
Singapore 1
Woodbridge 1
Zhengzhou 1
Totale 147
Nome #
Estimating 12-week death probability in patients with refractory metastatic colorectal cancer: The Colon Life nomogram 60
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study 55
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial 39
Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trial 30
An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer 13
Totale 197
Categoria #
all - tutte 1.300
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.300


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 0 0 0 0 0 0 5 0
2020/202110 2 0 1 1 0 0 0 1 1 2 1 1
2021/202213 1 0 1 1 0 0 0 2 0 0 3 5
2022/2023101 2 11 0 4 3 14 10 22 15 0 11 9
2023/202460 0 4 5 5 5 7 1 14 1 10 1 7
2024/20258 8 0 0 0 0 0 0 0 0 0 0 0
Totale 197